Alchemab Therapeutics is a UK-based clinical-stage biotechnology company developing next-generation antibody therapeutics for hard-to-treat diseases. Its "Adaptive Immunity" platform identifies naturally resilient individuals, such as long-term cancer survivors, and harnesses their protective antibodies, using artificial intelligence and deep… - View it on GitHub